Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
18.03
-0.76 (-4.04%)
May 14, 2026, 11:45 AM EDT - Market open
Summit Therapeutics Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$30.54
Upside
+69.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $23 | Strong Buy | Maintains | $30 → $23 | +27.57% | May 4, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | -11.26% | May 1, 2026 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +149.58% | Apr 8, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $42 → $15 | Strong Buy → Hold | Downgrades | $42 → $15 | -16.81% | Mar 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $30 | Strong Buy | Maintains | $40 → $30 | +66.39% | Feb 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +121.85% | Feb 2, 2026 |
| Citizens | Citizens | Buy Reiterates $40 | Buy | Reiterates | $40 | +121.85% | Jan 30, 2026 |
| Barclays | Barclays | Sell → Hold Upgrades $16 → $18 | Sell → Hold | Upgrades | $16 → $18 | -0.17% | Dec 17, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +121.85% | Oct 22, 2025 |
| Barclays | Barclays | Sell Maintains $13 → $16 | Sell | Maintains | $13 → $16 | -11.26% | Oct 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +121.85% | Oct 21, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $35 → $40 | Strong Buy | Maintains | $35 → $40 | +121.85% | Oct 20, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $40 | Buy | Reiterates | $40 | +121.85% | Oct 20, 2025 |
| Barclays | Barclays | Sell Initiates $13 | Sell | Initiates | $13 | -27.90% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +177.32% | Sep 16, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.